I. Zimmermann

543 total citations
65 papers, 348 citations indexed

About

I. Zimmermann is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, I. Zimmermann has authored 65 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 37 papers in Physiology and 9 papers in Immunology and Allergy. Recurrent topics in I. Zimmermann's work include Asthma and respiratory diseases (33 papers), Respiratory and Cough-Related Research (20 papers) and Inhalation and Respiratory Drug Delivery (16 papers). I. Zimmermann is often cited by papers focused on Asthma and respiratory diseases (33 papers), Respiratory and Cough-Related Research (20 papers) and Inhalation and Respiratory Drug Delivery (16 papers). I. Zimmermann collaborates with scholars based in Germany, Switzerland and Portugal. I. Zimmermann's co-authors include W. T. Ulmer, H Magnussen, Richard A. Kroczek, M. Falqués, Esther García Gil, Diana Jarreta, Henrik Watz, W Ritzerfeld, Erica A. Voss and B. A. Stuck and has published in prestigious journals such as Nature Communications, Journal of Antimicrobial Chemotherapy and Journal of Molecular Medicine.

In The Last Decade

I. Zimmermann

59 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Zimmermann Germany 9 144 143 60 50 42 65 348
Luis Vizcaíno Spain 9 62 0.4× 111 0.8× 91 1.5× 86 1.7× 77 1.8× 13 390
Thomas Troost United States 11 163 1.1× 174 1.2× 35 0.6× 20 0.4× 41 1.0× 21 401
Shengdao Xiong China 12 153 1.1× 165 1.2× 64 1.1× 19 0.4× 56 1.3× 40 393
Fehmi Döner Türkiye 12 70 0.5× 76 0.5× 19 0.3× 69 1.4× 13 0.3× 31 377
Mayumi Yamamoto Japan 12 224 1.6× 480 3.4× 46 0.8× 63 1.3× 53 1.3× 28 660
MW Lin Taiwan 5 29 0.2× 113 0.8× 99 1.6× 99 2.0× 25 0.6× 7 411
Valentin Popa United States 11 184 1.3× 145 1.0× 21 0.3× 49 1.0× 26 0.6× 25 315
Masatsugu Ohtsuki Japan 11 44 0.3× 85 0.6× 39 0.7× 29 0.6× 61 1.5× 31 436
Ronald M. Ferdman United States 9 39 0.3× 91 0.6× 49 0.8× 77 1.5× 15 0.4× 23 289
C. Baumgarten Germany 10 106 0.7× 229 1.6× 37 0.6× 180 3.6× 28 0.7× 25 419

Countries citing papers authored by I. Zimmermann

Since Specialization
Citations

This map shows the geographic impact of I. Zimmermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Zimmermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Zimmermann more than expected).

Fields of papers citing papers by I. Zimmermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Zimmermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Zimmermann. The network helps show where I. Zimmermann may publish in the future.

Co-authorship network of co-authors of I. Zimmermann

This figure shows the co-authorship network connecting the top 25 collaborators of I. Zimmermann. A scholar is included among the top collaborators of I. Zimmermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Zimmermann. I. Zimmermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zimmermann, I., Cláudia Campos, Stephanie Könen‐Waisman, et al.. (2019). Molecular mechanism for the control of virulent Toxoplasma gondii infections in wild-derived mice. Nature Communications. 10(1). 1233–1233. 27 indexed citations
2.
Heiser, Clemens, I. Zimmermann, J. Ulrich Sommer, et al.. (2013). Pharyngeal Chemosensitivity in Patients with Obstructive Sleep Apnea and Healthy Subjects. Chemical Senses. 38(7). 595–603. 12 indexed citations
3.
Magnussen, H, Henrik Watz, I. Zimmermann, et al.. (2009). Peak inspiratory flow through the Genuair® inhaler in patients with moderate or severe COPD. Respiratory Medicine. 103(12). 1832–1837. 58 indexed citations
4.
Strecker, Thomas, I. Zimmermann, Gregor Schlüter, & Richard Feyrer. (2009). Antikoagulation in der Schwangerschaft nach künstlichem Herzklappenersatz. DMW - Deutsche Medizinische Wochenschrift. 134(42). 2116–2119. 1 indexed citations
5.
Nowak, Dennis, Françoise Arnaud, H Fabel, et al.. (1990). Peripheral neuropathies in patients with chronic obstructive pulmonary disease: A multicenter prevalence study. Lung. 168(1). 43–51. 18 indexed citations
6.
Zimmermann, I., et al.. (1989). Controlled prospective study of oral amoxycillin/clavulanate vs ciprofloxacin in acute exacerbations of chronic bronchitis. Journal of Antimicrobial Chemotherapy. 24(suppl B). 185–193. 16 indexed citations
7.
Zimmermann, I., et al.. (1989). Influence of picumast dihydrochloride on the ex vivo histamine release from leucocytes of allergic asthmatic patients.. PubMed. 39(10A). 1351–3. 1 indexed citations
8.
Kroczek, Richard A., et al.. (1986). Cloverleaf skull associated with Pfeiffer syndrome: pathology and management. European Journal of Pediatrics. 145(5). 442–445. 26 indexed citations
9.
Rasche, B., et al.. (1984). Release of histamine and catecholamines in experimental asthma in dogs.. PubMed. 38(4). 269–77. 1 indexed citations
10.
Zimmermann, I., et al.. (1983). Histamine release into cracheal lumen and bronchial reactivity. Research in Experimental Medicine. 182(2). 167–175. 3 indexed citations
11.
Zimmermann, I., et al.. (1981). [Pathophysiology of bronchial obstruction].. PubMed. 87. 229–39. 1 indexed citations
12.
Ulmer, W. T. & I. Zimmermann. (1981). A Controlled Trial of Amoxycillin with Clavulanic Acid (BRL 25000) against Doxycycline in Chronic Bronchitis. Journal of International Medical Research. 9(5). 372–377. 11 indexed citations
13.
Zimmermann, I. & W. T. Ulmer. (1980). Arterielle Plasma-Histaminkonzentration bei von verschiedenen Arealen des Bronchialsystems ausgelöster Atemwegsobstruktion. Research in Experimental Medicine. 177(3). 193–200. 6 indexed citations
14.
Zimmermann, I., et al.. (1980). Wirkung von Acetylcholin- und Histamininhalationen sowie Hypoxie auf die arterielle Plasma-Histaminkonzentration (Versuche an Hunden). Research in Experimental Medicine. 177(3). 181–191. 8 indexed citations
15.
16.
Zimmermann, I., et al.. (1980). Wirkort von ?2-Receptoren stimulierenden Bronchodilatatoren. Journal of Molecular Medicine. 58(8). 395–402. 2 indexed citations
17.
Zimmermann, I.. (1979). [The condition of the periodontium in patients with clefts].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 29(12). 892–7.
18.
Zimmermann, I., et al.. (1978). [Blood level courses after i.v., i.m. and p.o. administration of theophylline ethylendiamine and pH-neutral solution of theophylline (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 28(9). 1652–4. 1 indexed citations
19.
Zimmermann, I. & W. T. Ulmer. (1977). Antigeninduzierte Atemwegsobstruktion und Empfindlichkeitssteigerung der Bronchomotorik. Respiration. 34(3). 141–151. 2 indexed citations
20.
Zimmermann, I., et al.. (1976). Effect of Unilateral Vagus Blockade on Antigen-Induced Airway Obstruction. Respiration. 33(5). 359–365. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026